- 专利标题: COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS
-
申请号: US18283406申请日: 2022-03-21
-
公开(公告)号: US20240216515A1公开(公告)日: 2024-07-04
- 发明人: Michael Torres , Daniel J. Siegwart , Jackson Eby , Rumpa Bhattacherjee , Brandon Wustman , Vladimir Kharitonov , Qiang Cheng , Tuo Wei
- 申请人: ReCode Therapeutics, Inc. , The Board of Regents of the University of Texas System
- 申请人地址: US CA Menlo Park
- 专利权人: ReCode Therapeutics, Inc.,The Board of Regents of the University of Texas System
- 当前专利权人: ReCode Therapeutics, Inc.,The Board of Regents of the University of Texas System
- 当前专利权人地址: US CA Menlo Park
- 国际申请: PCT/US2022/021176 2022.03.21
- 进入国家日期: 2023-09-21
- 主分类号: A61K47/54
- IPC分类号: A61K47/54 ; A61K47/14 ; A61K47/24 ; A61K47/28 ; C12N15/113
摘要:
Described herein are compositions, kits, and methods for potent delivery to a ceil of a subject. The cell can be of a particular cell type, such as a basal cell. In some cases, the cell can be a lung cell of a particular cell type. Also described herein are pharmaceutical compositions comprising a therapeutic or prophylactic agent assembled with a lipid composition. Tire lipid composition can comprise an ionizable cationic lipid, and a selective organ targeting lipid. The lipid composition can further comprise a phospholipid. Further described herein are high-potency intravenous dosage forms of a therapeutic or prophylactic agent formulated with a lipid composition.
信息查询